title: Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels.
abstract: Atopy is an immune disorder in which a Th2 dominant mechanism leads to high IgE levels and the clinical disorder asthma. It has been postulated that the Th1 cytokine IFNgamma, acting through its heterodimeric receptors, IFNgammaR1 and IFNgammaR2, in the induction/proliferation of Th1 cells, might suppress the Th2 responses that may underlie atopic asthma. However, neither murine nor human variants of IFNgamma associate with atopy. Several dysfunctional mutations have been identified in IFNgamma receptor genes (IFNGR1 and IFNGR2) in relation to severe and selective infections with poorly pathogenic organisms. However, little is known about common polymorphisms and their functional role in atopy. To test whether such variants of IFNGR1 and IFNGR2 relate to atopic asthma, we conducted a genetic association study in both British (n = 300) and Japanese (n = 200) populations. An intronic variant of IFNGR1 showed marginal association with total serum IgE levels in the British population compared with those with total IgE levels <30 IU/ml and those with >120-500 IU/ml [odds ratio = 2.00 (95% CI 1. 00-4.07), P = 0.048]. A coding variant, Gln64Arg of the IFNGR2, also associated with total serum IgE levels in the British population [chi(2) = 5.08, P = 0.024]. Further genetic and functional analyses are needed to clarify the role of variants of IFNgamma receptor genes in atopic immune disorder among different ethnic groups.
authors.affiliation: Experimental Medicine Unit, University of Wales Swansea, Swansea, United Kingdom.
authors.forename: P S
authors.initials: PS
authors.lastname: Gao
authors.forename: X Q
authors.initials: XQ
authors.lastname: Mao
authors.forename: E
authors.initials: E
authors.lastname: Jouanguy
authors.forename: A
authors.initials: A
authors.lastname: Pallier
authors.forename: R
authors.initials: R
authors.lastname: Döffinger
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Nakashima
authors.forename: T
authors.initials: T
authors.lastname: Otsuka
authors.forename: M H
authors.initials: MH
authors.lastname: Roberts
authors.forename: T
authors.initials: T
authors.lastname: Enomoto
authors.forename: Y
authors.initials: Y
authors.lastname: Dake
authors.forename: M
authors.initials: M
authors.lastname: Kawai
authors.forename: S
authors.initials: S
authors.lastname: Sasaki
authors.forename: S R
authors.initials: SR
authors.lastname: Shaldon
authors.forename: P
authors.initials: P
authors.lastname: Coull
authors.forename: C N
authors.initials: CN
authors.lastname: Adra
authors.forename: Y
authors.initials: Y
authors.lastname: Niho
authors.forename: J L
authors.initials: JL
authors.lastname: Casanova
authors.forename: T
authors.initials: T
authors.lastname: Shirakawa
authors.forename: J M
authors.initials: JM
authors.lastname: Hopkin
mesh_terms: D001249:Asthma / Q000209:etiology / Q000235:genetics*; D014644:Genetic Variation; D005838:Genotype; D006969:Hypersensitivity, Immediate / Q000209:etiology / Q000235:genetics*; D007073:Immunoglobulin E / Q000097:blood*; D007371:Interferon-gamma / Q000378:metabolism; D007564:Japan; D017471:Receptors, Interferon / Q000235:genetics* / Q000378:metabolism; D018417:Th1 Cells; D018418:Th2 Cells; D006113:United Kingdom; D000096743:Interferon gamma Receptor
chemical_list: D007073:Immunoglobulin E; D007371:Interferon-gamma; D017471:Receptors, Interferon; D000096743:Interferon gamma Receptor